By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Rhoen-Klinikum AG

Rhoen-Klinikum AG (RKAGY)

OTC Market Data in USD, Fundamentals in EUR
$7.37
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$986.63M
Market Cap
15.96
P/E Ratio (TTM)
0.74%
Forward Dividend Yield
$6.05 - $9.07
52 Week Range

RKAGY Stock Price Chart

Explore Rhoen-Klinikum AG interactive price chart. Choose custom timeframes to analyze RKAGY price movements and trends.

RKAGY Company Profile

Discover essential business fundamentals and corporate details for Rhoen-Klinikum AG (RKAGY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

12 Jun 2013

Employees

18.82K

CEO

Stefan Stranz

Description

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.

RKAGY Financial Timeline

Browse a chronological timeline of Rhoen-Klinikum AG corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 May 2026

Upcoming earnings on 25 Mar 2026

Upcoming earnings on 6 Nov 2025

Earnings released on 7 Aug 2025

EPS came in at $0.12 , while revenue for the quarter reached $493.09M .

Earnings released on 8 May 2025

EPS came in at $0.12 , while revenue for the quarter reached $454.65M .

Dividend declared on 7 May 2025

A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 23 Jun 2025.

Earnings released on 27 Mar 2025

EPS came in at $0.23 , while revenue for the quarter reached $439.63M .

Earnings released on 7 Nov 2024

EPS came in at $0.16 , while revenue for the quarter reached $433.80M .

Earnings released on 8 Aug 2024

EPS came in at $0.15 , while revenue for the quarter reached $494.01M .

Earnings released on 8 May 2024

EPS came in at $0.17 , while revenue for the quarter reached $411.25M .

Earnings released on 28 Mar 2024

EPS came in at $0.18 , while revenue for the quarter reached $380.58M .

Earnings released on 31 Dec 2023

EPS came in at $0.26 , while revenue for the quarter reached $412.44M .

Earnings released on 30 Jun 2023

EPS came in at $0.09 , while revenue for the quarter reached $399.99M .

Dividend declared on 26 May 2023

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 28 Jun 2023.

Earnings released on 31 Mar 2023

EPS came in at $0.10 , while revenue for the quarter reached $393.03M .

Earnings released on 31 Dec 2022

EPS came in at $0.14 , while revenue for the quarter reached $408.07M .

Earnings released on 30 Sept 2022

EPS came in at $0.04 , while revenue for the quarter reached $347.72M .

Earnings released on 30 Jun 2022

EPS came in at $0.08 , while revenue for the quarter reached $380.65M .

Earnings released on 31 Mar 2022

EPS came in at $0.01 , while revenue for the quarter reached $384.15M .

Earnings released on 31 Dec 2021

EPS came in at $0.53 , while revenue for the quarter reached $421.13M .

Earnings released on 30 Sept 2021

EPS came in at $0.06 , while revenue for the quarter reached $403.63M .

Earnings released on 30 Jun 2021

EPS came in at $0.06 , while revenue for the quarter reached $411.57M .

Earnings released on 31 Mar 2021

EPS came in at $0.01 , while revenue for the quarter reached $395.09M .

Earnings released on 31 Dec 2020

EPS came in at -$0.00 , while revenue for the quarter reached $418.74M .

Earnings released on 30 Sept 2020

EPS came in at $0.05 , while revenue for the quarter reached $408.79M .

RKAGY Stock Performance

Access detailed RKAGY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run